Seven Eight Capital’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,575
Closed -$257K 687
2023
Q1
$257K Sell
6,575
-5,537
-46% -$271K 0.05% 359
2022
Q4
$640K Buy
+12,112
New +$590K 0.17% 183

Other funds holding SILK

Seven Eight Capital's SILK Position: Q2 2023 in Review

Seven Eight Capital sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2023, closing a stake of 6,575 shares — an estimated $257K sold.

Seven Eight Capital first reported a position in SILK in Q4 2022 and held it in 2 quarters. The position peaked at $640K in Q4 2022. 173 funds tracked by Wall St. Rank hold SILK as of Q2 2023.

  • Seven Eight Capital reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Seven Eight Capital sold 6,575 Silk Road Medical, Inc. Common Stock shares in Q2 2023, an estimated $257K.
  • Seven Eight Capital first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Seven Eight Capital's Silk Road Medical, Inc. Common Stock position peaked at $640K in Q4 2022.
  • 173 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2023.

Based on Seven Eight Capital's 13F filing for Q2 2023, filed 14 Aug 2023.